U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07717385) titled 'Sleep More, Stress Less: 90-Day Trial of Neuralli Mood' on July 13.

Brief Summary: This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condit...